化合物PD 198306 T21980
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 212631-61-3 | ¥990.00 | 询底价 |
500 mg | 212631-61-3 | ¥9,420.00 | 询底价 |
1 mg | 212631-61-3 | ¥432.00 | 询底价 |
100 mg | 212631-61-3 | ¥4,720.00 | 询底价 |
1 mL | 212631-61-3 | ¥1,060.00 | 询底价 |
50 mg | 212631-61-3 | ¥3,370.00 | 询底价 |
10 mg | 212631-61-3 | ¥1,450.00 | 询底价 |
25 mg | 212631-61-3 | ¥2,370.00 | 询底价 |
Product Introduction
Bioactivity
英文名: PD 198306
描述: PD 198306 是一种具有抗痛觉过敏作用的 MAPK/ERK 激酶 (MEK) 选择性抑制剂。 PD 198306 可降低链脲佐菌素诱导的活性 ERK1 水平升高。
体外活性: PD 198306(10 μM)在18小时和36小时时,分别降低了Tha-Crimson复制30%和50%。同样,PD 198306(10 μM)显著抑制了Tha-GFP复制25%[1]。
体内活性: In male Sprague Dawley rats bearing neuropathic pain, PD 198306 (1-30 μg/10 μL; i.t.) dose-dependently blocks static allodynia in both the chronic constriction injury and the streptozocin models[2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 45 mg/mL (94.49 mM)
关键字: MAPK | inhibit | neuropathic | Inhibitor | MAP2K | rabies | mitogen-activated protein | drug | MAPKK | phosphatases | inositol | RNA | pain | PD198306 | interference | MEK | ERK | PD 198306 | antihyperalgesic | screening | Mitogen-activated protein kinase kinase | phosphate | kinases | PD-198306
相关产品: GW 284543 hydrochloride | TAK-285 | BMS-599626 | Trametinib | APS-2-79 hydrochloride | Corylifol C | URMC-099 | AZD8330 | Ro 5126766 | Isorhamnetin
相关库: Anti-Prostate Cancer Compound Library | Anti-Liver Cancer Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Anti-Ovarian Cancer Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Colorectal Cancer Compound Library | Anti-Obesity Compound Library | Bioactive Compound Library
化合物PD 198306 T21980信息由TargetMol中国为您提供,如您想了解更多关于化合物PD 198306 T21980报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途